Evidence map›Paper›PMID 28617238›Full record

ArticleHealthcare policy = Politiques de sante2017

Public Health Policy in Support of Insurance Coverage for Smoking Cessation Treatments.

Robert Schwartz, Farzana Haji, Alexey Babayan, Christopher Longo, Roberta Ferrence

Abstract read
In one paragraph

Article in Healthcare policy = Politiques de sante, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Robert SchwartzOntario Tobacco Research Unit, Dalla Lana School of Public Health, Centre for Addictions and Mental Health, University of Toronto, Toronto, ON.
Farzana HajiOntario Tobacco Research Unit, Dalla Lana School of Public Health, University of Toronto, Toronto, ON.
Alexey BabayanOntario Tobacco Research Unit, Dalla Lana School of Public Health, University of Toronto, Toronto, ON.
Christopher LongoDeGroote School of Business, McMaster University, Hamilton, ON.
Roberta FerrenceOntario Tobacco Research Unit, Dalla Lana School of Public Health, University of Toronto, Toronto, ON.

Funding

CIHR
6 · The paper itself

Abstract

Insurance coverage for evidence-based smoking cessation treatments (SCTs) promotes uptake and reduces smoking rates. Published studies in this area are based in the US where employers are the primary source of health insurance. In Ontario, Canada, publicly funded healthcare does not cover SCTs, but it can be supplemented with employer-sponsored benefit plans. This study explores factors affecting the inclusion/exclusion of smoking cessation (SC) benefits. In total, 17 interviews were conducted with eight employers (auto, retail, banking, municipal and university industries), four health insurers, two government representatives and three advisors/consultants. Overall, SCT coverage varied among industries; it was inconsistently restrictive and SCT differed by coverage amount and length of use. Barriers impeding coverage included the lack of the following: Canadian-specific return on investment (ROI), SC cost information, employer demand, government regulations/incentives and employee awareness of and demand. A Canadian evidence-based calculation of ROI for SC coupled with government incentives and public education may be needed to promote uptake of SCT coverage by employers.

Indexed as

Health Benefit Plans, EmployeeHealth PolicyInsurance CoverageSmoking CessationHumansOntario

Identifiers

PMID28617238
PMCPMC5473475

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.